In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent (Q35257842)

7 August 2017

title

In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent (English)

1 reference

7 August 2017

Tanio T

1

1 reference

7 August 2017

Ichise K

series ordinal

2

1 reference

7 August 2017

Nakajima T

series ordinal

3

1 reference

7 August 2017

Okuda T

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 June 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

980-984

1 reference

Itraconazole, a new triazole that is orally active in aspergillosis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Activity of SM-4470, a new imidazole derivative, against experimental fungal infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Activity of ICI 195,739--a novel, orally active bistriazole--in rodent models of fungal and protozoal infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Itraconazole treatment of experimental systemic candidiasis in male rats

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Itraconazole: pharmacologic studies in animals and humans.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Pharmacokinetics of itraconazole following oral administration to normal volunteers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Itraconazole therapy for cryptococcal meningitis and cryptococcosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Efficacy of SCH39304 in murine cryptococcosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Treatment of invasive aspergillosis with itraconazole

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Antimycotic activity of BAY N 7133 in animal experiments

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171742

Experience with itraconazole in cryptococcosis and aspergillosis

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2203310

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.34.6.980

1 reference

7 August 2017

1 reference

7 August 2017

1 reference